During this time of extremely high call volume, our team is working diligently to respond to inquiries as quickly as possible on the day they are received. 


If you have not received a response from our team or your submitted documents show as pending in your portal, please know these are in queue to be reviewed in the order they are received. Submitting multiple emails, portal messages, or phone calls adds time to the review process for our team and results in additional delays in our ability to respond to inquiries.  


To help us better assist you, please utilize one of the following options: 1. Visit your respective patient, provider, or pharmacy portal to enroll, re-enroll, or check grant status. It takes approximately 10 minutes to apply on average, and your application is acted on in real time: https://healthwellfoundation.my.salesforce-sites.com/patients.  2. Email grants@healthwellfoundation.org if your inquiry cannot be answered via the portals. 3. Request a callback through our interactive voice response system and a representative will respond to your inquiry on the same day it is received (note, this may be outside of normal business hours). 


We understand the importance of timely and complete responses and serving you is our number one priority. Please help us help you by submitting one inquiry only.  


Thank you for your patience during this time. 

Dismiss alert

Chronic Lymphocytic Leukemia

Treatments Covered

  • Adriamycin
  • Arranon
  • Arzerra
  • Bendeka
  • Betamethasone Valerate
  • Brukinsa
  • Calquence
  • Cladribine
  • Copiktra
  • Cyclophosphamide
  • Cycophosphamide Intra Sol
  • Cytarabine
  • Decadron
  • Elitek
  • Etoposide Novaplus
  • Fludarabine
  • Gammagard
  • Gamunex-c
  • Gazyva
  • Hizentra
  • Hydrocortisone
  • Hyqvia
  • Imbruvica
  • Imbruvica/gazyva Ccombo
  • Immune Globulin
  • Immune Globulin Intravenous (ivig Or Igiv)
  • Jaypirca
  • Keytruda
  • Lemtrada
  • Lenalidomide
  • Leukeran
  • Medrol
  • Millipred
  • Millipred Dp
  • Mitoxantrone
  • Nipent
  • Octagam
  • Opdivo
  • Otrexup
  • Pirtobrutinib
  • Prednisone
  • Privigen
  • Rasburicase
  • Rasuvo
  • Revlimid
  • Riabni
  • Rituxan
  • Rituxan Hycela
  • Rituximab
  • Rituximab-pvvr
  • Ruxience
  • Toposar
  • Toposar Novaplus
  • Treanda
  • Truxima
  • Valchlor
  • Venclexta
  • Vincasar
  • Xatmep
  • Zydelig

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment of chronic lymphocytic leukemia.

Grant Utilization

HealthWell estimates that patients use an average of $5,560 during their 12-month grant period for this disease area.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • To qualify for assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.

  • HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

About Chronic Lymphocytic Leukemia

Leukemia is cancer that starts in the blood-forming cells of the bone marrow. When one of these cells changes and becomes a leukemia cell, it no longer matures the way it should and grows out of control. Often, it divides to make new cells faster than normal. According to the American Cancer Society, chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. CLL starts in cells that become certain white blood cells (called lymphocytes) in the bone marrow. The cancer (leukemia) cells start in the bone marrow but then go into the blood.

In CLL, the leukemia cells often build up slowly. Over time, the cells grow and spread to other parts of the body, including the lymph nodes, liver, and spleen. Source: American Cancer Society

Close menu